Skip to main content
. 2016 Mar 9;14:17. doi: 10.1186/s12951-016-0172-2

Table 2.

Selected examples of investigations where the anti-tumor agent was protected by an NP during transport through the body and where the antineoplastic effect was expressed prolonged survival

Nanoparticle Targeting ligand Therapeutic agent Tumor Animal Ref.
Polymer Biotin Paclitaxel + tariquidar “transformed murine” Mice [153]
Polymer None Dox/curcumin Four human malignancies Mice [265]
Liposome Peptide Dox Human neuroblastoma Mice [266]
Chitosan-NP mirRNA Paclitaxel Human ovarian cancer Mice [267]
Polymer Local injector Dithiazanin MGB Rats [268]
Polymer Abs, vs ABC G2 Paclitaxel + siRNA Human breast cancer Mice
Polymer None stated Dox + Mitomyzin Human breast cancer Mice [269]
Polymer Photodynamic and chemotherapy Dox Human breast cancer Mice [270]

GR growth reduction, PS prolonged survival, Wt wild type